TrialReader


UV Dosimetry Feedback in NMSC Patients

NCT03757663 — Not applicable, Withdrawn, University of Colorado, Denver

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

UV Dosimetry Feedback in Non-Melanoma Skin Cancer Patients

RegistryNCT03757663
StatusWithdrawn - Study closed
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, prevention
SponsorUniversity of Colorado, Denver (Other)
ConditionsNon-Melanoma Skin Cancer
InterventionsUV Counseling (Behavioral)
Datesstart 2018-03-12, primary completion 2019-08-30, completion 2019-08-30, first posted 2018-11-29, last updated 2019-09-06
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Non-Melanoma Skin Cancer All trials of UV Counseling

-Summary

This study aims to characterize UV exposures among NMSC patients (those with a history of skin cancer) and to pilot an innovative behavioral intervention to decrease modifiable UV exposures. It will use UV dosimeters to objectively measure UV exposure and provide time and activity specific UV data on an individual level. These data will be used to develop a targeted and personalized behavioral feedback plan with counseling aimed at effective sun exposure behavior change

Expand all sections  ·  Collapse all

+Detailed description

The study will focus on helping to prevent NMSC and its associated morbidity through learning when patients are unintentionally exposed to extreme UV radiation. It will then help to create manageable and realistic behavioral interventions to reduce exposure, while also educating patients of the dangers of abundant sun exposure.

+Arms and interventions

ArmTypeInterventionsDescription
UV DosimeterExperimentalBehavioral: UV CounselingUV Dosimeter will measure participants' UV exposure for two separate 3-week periods.
  • UV Counseling (Behavioral): Participants will self-report their knowledge and attitudes related to UV exposure. They will then wear a dosimeter for 3 weeks. After, the study team will counsel the participants on their UV levels and exposure, creating a personal plan and advice for avoiding sun exposure before letting the participants wear the dosimeter for an additional 3 weeks.

+Outcome measures

Primary outcomes

  • Identify Discrepancies of Self-Reported Sun Exposure and Actual Sun Exposure [Start of study to end of study, up to 3 months]: Measured using individual dosimeters and comparing it to what participants state they believe their level of sun exposure is
  • Identify Discrepancies of Self-Reported Sun Exposure and Actual Sun Exposure [Start of study to end of study, up to 3 months]: Compare specific sun exposure behaviors responsible for the level of exposure versus what could be done to lessen it

Secondary outcomes

  • Behavioral Intervention and immediate follow-up [Start of study to end of study, up to 3 months]: Participants will receive a personalized feedback plan and the success of the plan will be measured through individual dosimetry. We will track real time change in sun exposure based on repeat UV dosimetry.
  • Long Term Follow Up - longitudinal change in sun exposure based on dosimetry [Start of study to end of study, up to 3 months]: Track the longitudinal change in sun exposure comparing baseline UV dosimetry measurements to 3 month follow up dosimetry measurements to determine if the changes observed in outcome 3 are maintained.

+Eligibility

Sex: All, ages: 18 Years to 50 Years

Inclusion Criteria:

* Patients between ages 18 and 50.
* Must be diagnosed with non-melanoma skin cancer.

Exclusion Criteria:

* Patients, who at the discretion of the clinician, are too ill or sick.
* Non-English speaking patients.

+Locations (1)

FacilityCityCountryStatus
University of ColoradoAurora, ColoradoUnited States

+Investigators

My Notes